will compound pharmacies stop making semaglutide Compounded Semaglutide: How to Better Ensure Its Safety Pharma's mess of its own

The same day-of-week considerations apply

Although compounded semaglutide is no longer permitted by the Food and Drug Administration (FDA), Noom appears to be utilizing a personalized treatment exception to market and sell its miniature GLP-1 injections

The earliest realistic timeline for UK availability is 2028 or later, following anticipated phase 3 data in 20252026, a potential MHRA submission in 20262027, and subsequent NICE appraisal

Liquid is simpler, more practical, and a measured tablespoon is harder to under-dose by accident

With insurance, prior authorization requirements and step-therapy protocols create multi-month delays even for patients who clearly meet clinical eligibility criteria